Gene detection of ultra-early cancer cells is an accurate and comprehensive screening technique for ultra-early cancer. By detecting a small number of tumor mutation genes in blood (ctDNA, that is, circulating tumor DNA, is the gold standard for early molecular mutation detection of tumors) for qualitative and quantitative analysis, "precancerous" lesions of the body can be found efficiently and accurately, which breaks through the key technical problem of detecting a small number of mutations from DNA slices after tumor cells die, and warns cancer risks 3-5 years in advance.
At present, the better project in the industry is the preTes ultra-early tumor screening test for middle-aged and elderly people, which can detect 49 cancer-related genes and 298 mutation sites at one time and screen 28 common tumors at the same time:
Suitable for people:
1, cancer high-risk population; 2. People suspected of cancer; 3. People after cancer surgery
I hope it helps you, take it ~